Introduction:
Medpharma has completed a major expansion project of its US Center of Excellence at an investment of US$4million in Durham, North Carolina.
Features:
The expansion has tripled the facility's footprint to approximately 25,000 sq.ft.
The investment in the project was done in response to the increasing demand for its topical and transdermal formulation development, and performance testing services.
Moreover, topical and transdermal services covering pre-formulation and formulation development, in-vitro release, in-vitro penetration/permeation, tissue culture, analytical/bioanalysis, custom device development, and tissue engineering are all part of the expansion.
Additionally, the new space will also include dedicated innovation, microbiology and histology labs.
As part of the investment, Medpharma has installed the latest Waters LC-MS/MS to manage the increasing demand for bio-analysis and has substantially increased its LC/MS capacity and the automation of sample handling.
This new model is equipped with the latest UPLC for rapid separation and method development and provides mass spectrometry detection at picogram levels.
Specifications:
| Name | Medpharma |
| Type | Expansion |
| Budget | US$4 million |
